Cvs Health CORP Form 4 insider transactions

CVS Health Corp. executive James David Clark reported a transaction involving the withholding of common stock to cover FICA taxes upon becoming retirement eligible.

CVS Health CFO Brian Newman disposed of 2,478 shares to satisfy tax withholding obligations following a restricted stock unit vesting.

CVS Health EVP and Chief Medical Officer Amy Compton-Phillips reported the surrender of 7,618 shares to cover tax obligations.

CVS Health Director Fernando Aguirre reported the sale of 19,924 shares of common stock across two transactions in May 2026.

Larry Robbins and Glenview Capital have significantly reduced their position in CVS Health through a series of open-market sales.

CVS Health director John E. Gallina acquired 1,447.5039 deferred stock units as part of the company's non-employee director compensation policy.

CVS Health Director Michael F. Mahoney acquired 1,737.0046 deferred stock units as part of the company's non-employee director compensation plan.

CVS Health Director Fernando Aguirre acquired 1,563 shares of common stock as part of a semi-annual retainer payment.

CVS Health Director Jeffrey R. Balser acquired 2,058 shares of common stock as part of a semi-annual retainer payment.

CVS Health Director J. Scott Kirby acquired 1,447 shares of common stock as part of a semi-annual retainer payment.

CVS Health Director Leslie V. Norwalk acquired 1,447 shares of common stock as part of a semi-annual retainer payment.

CVS Health Director Guy P. Sansone acquired 1,447 shares of common stock as part of a semi-annual retainer payment.

CVS Health director Alecia A. DeCoudreaux acquired 1,447.5039 deferred stock units as part of the company's non-employee director compensation policy.

CVS Health director Anne Finucane acquired 1,544.0041 deferred stock units as part of the company's non-employee director compensation policy.

CVS Health Director C. David Brown II acquired 1,544 shares of common stock as part of a semi-annual retainer payment.

CVS Health Director Douglas H. Shulman acquired 1,447.5039 deferred stock units, scheduled for issuance on May 14, 2026, as part of his compensation plan.

CVS Health Director Larry Robbins acquired 1,930 deferred stock units as part of a semi-annual retainer deferral plan.

CVS Health EVP and Chief Experience & Technology Officer Tilak Mandadi sold 69,551 shares of common stock on May 8, 2026.

CVS Health Corp. executive Prem S. Shah reported transactions involving restricted stock units and stock options.

CVS Health Corp. executive Brian Newman reported transactions involving restricted stock units and stock options.

Steven H. Nelson, EVP and President of Aetna at CVS Health, reported transactions involving restricted stock units and common stock.

CVS Health executive Tilak Mandadi reported transactions involving restricted stock units and stock options, reflecting changes in beneficial ownership.

CVS Health Corp. executive Samrat S. Khichi reported transactions involving restricted stock units and common stock, including the surrender of shares for tax payments.

CVS Health Corp. executive J. David Joyner reported transactions involving restricted stock units and common stock, including the surrender of shares for tax payments.

Amy Compton-Phillips, EVP and Chief Medical Officer of CVS Health, reported transactions involving restricted stock units and stock options.

CVS Health Corp. executive James David Clark reported transactions involving restricted stock units and common stock, including the surrender of shares for tax withholding.

Heidi B. Capozzi, EVP and Chief People Officer at CVS Health Corp, reported transactions involving restricted stock and stock options.

CVS Health Corp Director John E. Gallina acquired 582 shares of common stock at $71.86 per share as part of a semi-annual retainer.

CVS Health EVP Samrat S. Khichi disposed of 7,886 shares of common stock to cover tax withholdings related to a restricted stock unit award.

CVS Health President and CEO J. David Joyner disposed of 1,944 shares of common stock to cover tax withholdings related to a restricted stock unit award.